The significant growth of the market can be attributed to growing number of geriatric population followed by increasing number of cancer patients. Moreover, technological advancements in ablation devices in emerging countries, is anticipated to boost the growth of the tumor ablation market over the forecast period. However, high cost of tumor ablation treatment is likely to restrain the market to a certain extent.
Major Key Players of the Tumor Ablation Market are:
Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, (Johnson & Johnson Services), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others.
According to World Health Organization, around 13% of the populace worldwide is aged 65 and above. The incidence of cancer is increasing with ageing. Around 60% of all cancer cases are diagnosed in patients aged 65 and above. Age related changes in the body are associated with an increased susceptibility to toxicity during chemotherapy and also, surgery is not offered to older patients mostly due to increased risk of surgical mortality. For the aged patients, who are not qualified for surgery and for whom chemotherapy is not a suitable option, there are technologies such as Radiofrequency Ablation (RFA), Microwave ablation (MWA) and Cryoablation to treat their cancer. This is expected to propel the growth of the Tumor Ablation Market.
The Tumor Ablation Market is segmented on the basis of Technology, Applications and region.
Major Technology of Tumor Ablation Market covered are:
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- High Intensity Focused Ultrasound (HIFU)
Major Applications of Tumor Ablation Market covered are:
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Bone Metastasis
- Breast Cancer
- Prostate Cancer
No comments:
Post a Comment